Shoulder Innovations, Inc. (SI) stock
SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3051% above fair value
$20.56+0.11 (+0.54%)
Close on Nov 17, 2026Market cap $428.04MP/E –Yield –
Shoulder Innovations operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Shoulder Innovations's operating cash flow for the twelve months ending Jun 30, 2026 was -$37.09M. For fiscal 2025 it was -$28.61M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$28.61M | – |
| FY2024 | Dec 31, 2024 | -$14.14M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.39M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.36M | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.78M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.56M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.80M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.48M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.27M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.89M | – |
See a number that looks wrong?